A new death receptor 3 isoform: expression in human lymphoid cell lines and non-Hodgkin's lymphomas

Biochemical and Biophysical Research Communications
K WarzochaG Salles

Abstract

Two isoforms encoding the full-length transmembrane death receptor 3 (DR3) were isolated from mRNAs of a panel of human cell lines and tumor tissues obtained from patients with follicular non-Hodgkin's lymphoma. A new DR3 variant (DR3 beta) was characterized by 2 insertions of respectively 20- and 7-base pairs (bp) which result in a predictive translated polypeptide differing from the described DR3 molecule by a 28 amino-acid stretch in the extracellular domain. DR3 was shown to be expressed in all cell lines and lymphoma samples tested, whereas DR3 beta expression was restricted to lymphoid T-cell and immature B-cell lines and to selected cases with follicular lymphoma. These data provide new insight into the molecular heterogeneity of DR3, suggesting the presence of several receptor isoforms that can participate in lymphoid cell homeostasis.

Citations

Apr 16, 2008·The Journal of Experimental Medicine·Lei FangEckhard R Podack
Apr 21, 2001·Molecular and Cellular Biology·E C WangM J Owen
Nov 17, 2014·BMC Nephrology·Jun WangJohn R Bradley
Jan 24, 2014·Mediators of Inflammation·Yoshihiro Aiba, Minoru Nakamura
Nov 19, 2013·Immunologic Research·Taylor H Schreiber, Eckhard R Podack
Nov 6, 2014·Molecular Medicine Reports·You Cheng ZhangFeng Xian Wei
Feb 8, 2005·Biochemical and Biophysical Research Communications·Christopher W BorysenkoHarry C Blair
Sep 21, 2006·Journal of Cellular Physiology·Christopher W BorysenkoHarry C Blair
Mar 1, 2011·Experimental and Therapeutic Medicine·Zhicheng GeWen G Jiang
Sep 30, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jun ZhangHongyu Luo

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

The Journal of Immunology : Official Journal of the American Association of Immunologists
Samia Q KhanEckhard R Podack
The Journal of Immunology : Official Journal of the American Association of Immunologists
Zi-Ming HuangChuen-Miin Leu
Liver International : Official Journal of the International Association for the Study of the Liver
Yoshihiro AibaMinoru Nakamura
© 2021 Meta ULC. All rights reserved